Press Releases
Ultimovacs Announces Resignation of Aitana Peire from Board of Directors
28, November, 2023
Ultimovacs ASA: New share capital registered
13, November, 2023
Ultimovacs ASA: Share capital increase related to exercise of options
9, November, 2023
Ultimovacs ASA Reports Third Quarter 2023 Financial Results and Provides General Business Update
8, November, 2023
See all
News
Biostock Article: About the NIPU study and interview with the Director of Medical Affairs at Ultimovacs, Espen Basmo Ellingsen
6, June, 2023
Ultimovacs Presentation at TD Cowen Healthcare Conference
6, March, 2023
Article published in Current Opinion in Oncology: “Therapeutic cancer vaccination against telomerase”
8, February, 2023
Interview with Professor Gustav Gaudernack (CSO) in BioStock
13, December, 2022
See all